Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders

被引:8
|
作者
Peng S. [1 ]
Dhawan V. [1 ]
Eidelberg D. [1 ]
Ma Y. [1 ]
机构
[1] Center for Neurosciences, Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, New York
关键词
Alzheimer’s disease; Bioelectronic medicine; Deep brain stimulation; Depression; DTI; Epilepsy; MRI; Multimodality neuroimaging; Obsessive compulsive disorder; Parkinson’s disease; PET; SPECT; Vagus nerve stimulation;
D O I
10.1186/s42234-021-00065-9
中图分类号
学科分类号
摘要
Brain stimulation technology has become a viable modality of reversible interventions in the effective treatment of many neurological and psychiatric disorders. It is aimed to restore brain dysfunction by the targeted delivery of specific electronic signal within or outside the brain to modulate neural activity on local and circuit levels. Development of therapeutic approaches with brain stimulation goes in tandem with the use of neuroimaging methodology in every step of the way. Indeed, multimodality neuroimaging tools have played important roles in target identification, neurosurgical planning, placement of stimulators and post-operative confirmation. They have also been indispensable in pre-treatment screen to identify potential responders and in post-treatment to assess the modulation of brain circuitry in relation to clinical outcome measures. Studies in patients to date have elucidated novel neurobiological mechanisms underlying the neuropathogenesis, action of stimulations, brain responses and therapeutic efficacy. In this article, we review some applications of deep brain stimulation for the treatment of several diseases in the field of neurology and psychiatry. We highlight how the synergistic combination of brain stimulation and neuroimaging technology is posed to accelerate the development of symptomatic therapies and bring revolutionary advances in the domain of bioelectronic medicine. © 2021, The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] Deep brain stimulation treatment for alcohol use disorders
    Kuhn, J.
    EUROPEAN PSYCHIATRY, 2019, 56 : S622 - S622
  • [32] Treatment of Pediatric Movement Disorders with Deep Brain Stimulation
    MacLean, J.
    Olaya, J.
    Liker, M.
    Sanger, T.
    ANNALS OF NEUROLOGY, 2023, 94 : S84 - S84
  • [33] The application of deep brain stimulation in the treatment of psychiatric disorders
    Graat, Ilse
    Figee, Martijn
    Denys, Damiaan
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2017, 29 (02) : 178 - 190
  • [34] Deep brain stimulation:: Neuropsychological and neuropsychiatric issues
    Voon, V
    Kubu, C
    Krack, P
    Houeto, JL
    Tröster, AI
    MOVEMENT DISORDERS, 2006, 21 : S305 - S327
  • [35] Letter to Editor: Neuropsychiatric Consequences of Deep Brain Stimulation in Patients with Chronic Movement Disorders
    Malakouti, Seyed Kazem
    Mahdavi, Seyed Reza
    Naji, Borzooyeh
    Asadi, Mina
    Kahani, Shamsoddin
    BASIC AND CLINICAL NEUROSCIENCE, 2016, 7 (03) : 185 - +
  • [36] Skin Conductance as a Viable Alternative for Closing the Deep Brain Stimulation Loop in Neuropsychiatric Disorders
    Wickramasuriya, Dilranjan S.
    Amin, Md Rafiul
    Faghih, Rose T.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [37] Neuroimaging the Effects of Deep Brain Stimulation for Compulsivity
    Figee, Martijn
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 16S - 16S
  • [38] Tickling the brain: New advances in brain stimulation are providing novel methods of treatment for neuropsychiatric disorders
    George, MS
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A48 - A48
  • [39] Brain Peptides for the Treatment of Neuropsychiatric Disorders
    Karatas, Hulya
    Yemisci, Muge
    Eren-Kocak, Emine
    Dalkara, Turgay
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (33) : 3905 - 3917
  • [40] Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
    Sethiya, Neeraj Kumar
    Ghiloria, Neha
    Srivastav, Akanksha
    Bisht, Dheeraj
    Chaudhary, Sushil Kumar
    Walia, Vaibhav
    Alam, Md. Sabir
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (07) : 865 - 882